CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 80 enrolled
Drug / intervention
Dysport +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01728337
NCT01728337Phase 4Completed
CompareCT.gov

Phase IV, Randomized, Double-blind Study on Muscle Activity of Two Commercial Preparations of Botulinum Toxin Type A (Dysport and Xeomin) Administered to the Upper Third of the Face (Forehead Lines).

Hexsel Dermatology Clinic·interventional·Posted Nov 19, 2012·Updated Jul 26, 2019

In Brief

A Phase 4 clinical trial evaluating Dysport and Xeomin for Sun-induced Wrinkles. Completed, enrolled 80 participants across 1 site.

Detailed Summary

this study was proposed to provide more scientific and objective data on the clinical and aesthetic effects of these two toxins (Dysport and Xeomin).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSun-induced Wrinkles
CountriesBrazil
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 19, 2012
Enrollment StartJul 1, 2011
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 13.6 years ago

Interventions

Dysportdrug

Dysport® was injected on the right side of the forehead and Xeomin® was injected on the left side of the forehead.

Xeomindrug

Xeomin® was injected on the right side of the forehead and Dysport® was injected on the left side of the forehead